AUDREY MEYER: Open Payments
NPI 1548318983 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 16 payments from 10 companies in 2025. Trend: 2023 $163 · 2024 $256 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $142 |
| Averitas Pharma Inc. | 2 | $70 |
| Merz Pharmaceuticals, LLC | 3 | $58 |
| SK Life Science, Inc. | 2 | $45 |
| Tanabe Pharma America, Inc. | 2 | $43 |
| UCB, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| ARGENX US, INC. | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: LINQ II, QUTENZA, INBRIJA, Radicava, INGREZZA, Zilbrysq, VYVGART HYTRULO, ULTOMIRIS.
Industry payments across GA — which companies pay providers there.
